NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.4680
-0.020936 (-4.28%)
At close: Aug 27, 2026
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $89.42 million as of August 28, 2026. Its market cap has increased by 816.14% in one year.
Market Cap
89.42M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.47
ChartMarket Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 89.42M, an increase of 3,140.65%. That is a compound annual growth rate of 26.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 89.42M | -66.06% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 305.55M |
| Glorywin Entertainment Group | 182.41M |
| Vaxart | 122.22M |
| HST Global | 91.93M |
| Sangamo Therapeutics | 63.55M |
| Nuo Therapeutics | 51.82M |
| Arch Biopartners | 47.47M |
| Vicapsys Life Sciences | 46.94M |